Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
82,113,528
-
Share change
-
-1,569,735
-
Total reported value
-
$2,121,588,355
-
Put/Call ratio
-
73%
-
Price per share
-
$25.84
-
Number of holders
-
236
-
Value change
-
-$24,472,655
-
Number of buys
-
106
-
Number of sells
-
116
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2017
As of 30 Jun 2017,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
236 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,113,528 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, D. E. Shaw & Co., Inc., DIMENSIONAL FUND ADVISORS LP, Consonance Capital Management LP, STATE STREET CORP, FRONTIER CAPITAL MANAGEMENT CO LLC, Camber Capital Management LLC, and THRIVENT FINANCIAL FOR LUTHERANS.
This page lists
236
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.